oleuropein-aglycone and Alzheimer-Disease

oleuropein-aglycone has been researched along with Alzheimer-Disease* in 2 studies

Reviews

1 review(s) available for oleuropein-aglycone and Alzheimer-Disease

ArticleYear
Benefit of Oleuropein Aglycone for Alzheimer's Disease by Promoting Autophagy.
    Oxidative medicine and cellular longevity, 2018, Volume: 2018

    Topics: Acetates; Alzheimer Disease; Animals; Autophagy; Cyclopentane Monoterpenes; Humans; Pyrans; TOR Serine-Threonine Kinases

2018

Other Studies

1 other study(ies) available for oleuropein-aglycone and Alzheimer-Disease

ArticleYear
EVOO Polyphenols Relieve Synergistically Autophagy Dysregulation in a Cellular Model of Alzheimer's Disease.
    International journal of molecular sciences, 2021, Jul-05, Volume: 22, Issue:13

    (1) Background: Autophagy, the major cytoplasmic process of substrate turnover, declines with age, contributing to proteostasis decline, accumulation of harmful protein aggregates, damaged mitochondria and to ROS production. Accordingly, abnormalities in the autophagic flux may contribute to many different pathophysiological conditions associated with ageing, including neurodegeneration. Recent data have shown that extra-virgin olive oil (EVOO) polyphenols stimulate cell defenses against plaque-induced neurodegeneration, mainly, through autophagy induction. (2) Methods: We carried out a set of in vitro experiments on SH-SY5Y human neuroblastoma cells exposed to toxic Aβ

    Topics: Acetates; Alzheimer Disease; Amyloid beta-Peptides; Autophagy; Cell Line; Cyclopentane Monoterpenes; Diet, Mediterranean; Humans; Mitochondria; Models, Neurological; Nerve Degeneration; Neurons; Olive Oil; Peptide Fragments; Phenylethyl Alcohol; Polyphenols; Proteasome Endopeptidase Complex; Pyrans; Reactive Oxygen Species; Ubiquitin

2021